Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

Odaia Raises $13.8 Million in Series A

Odaia, a Toronto, Ontario, Canada, and Boston, MA-based AI-powered commercial insights SaaS platform for pharmaceutical companies, closed a $13.8 million in Series A funding.

Ben Murray profile image
by Ben Murray
Odaia Raises $13.8 Million in Series A

Odaia, a Toronto, Ontario, Canada, and Boston, MA-based AI-powered commercial insights SaaS platform for pharmaceutical companies, closed a $13.8 million in Series A funding.

The round was led by Flint Capital, with participation from Innospark Ventures, Alumni Ventures, Graphite Ventures, and current investors BDC Capital’s Women in Tech Fund, MaRS IAF, StandUp Ventures, Panache Ventures, and others.

Funds will be used to enhance platform features and to expand sales, marketing, and customer success teams to support market expansion.

Andrew Gershfeld, who currently serves as Partner at Flint Capital, will advise ODAIA and represent Flint on the ODAIA board of directors. Also joining ODAIA’s board of directors is Matt Fates, Venture Partner at Innospark Ventures.

Company: ODAIA Intelligence Inc.

Raised: $13.8M

Round: Series A

Funding Month: February 2022

Lead Investors: Flint Capital

Additional Investors: Innospark Ventures, Alumni Ventures, Graphite Ventures, and current investors BDC Capital’s Women in Tech Fund, MaRS IAF, StandUp Ventures, and Panache Ventures

Company Website: https://odaia.ai/

Software Category: AI-powered commercial insights SaaS platform

About the Company: ODAIA was founded within the University of Toronto in 2018 after years of research and development in the areas of process mining, customer journey mapping, and AI. Led by Philip Poulidis, co-founder & CEO, Odaia is a SaaS company combining multivariate data analysis, process mining, and AI to offer predictive analytics to pharmaceutical and life sciences, commercial teams. Many of the world’s largest pharmaceutical companies have leveraged MAPTUAL for actionable commercial insights including Janssen, Novo Nordisk, AstraZeneca, among others. MAPTUAL consolidates a pharma company’s internal and external data and applies advanced analytics and machine learning to deliver predictive insights in real-time to sales and marketing teams, including predictive targeting and sales forecasting, physician segmentation, omnichannel attribution and next-best-engagement, allowing them to deploy resources more efficiently and create personalized customer engagements. 

 

Source: https://www.finsmes.com/2022/02/odaia-raises-13-8m-in-series-a-funding.html https://www.odaia.ai/post/odaia-raises-series-a-funding-in-an-oversubscribed-round

 

 

 

Ben Murray profile image
by Ben Murray

Subscribe to New Posts

Learn what companies and software categories are raising!

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

Read More